Company Filing History:
1 out of 8,373 
1 out of 62 
1 out of 504 
Years Active: 2018
Title: Irina M Shapiro: Innovator in Cancer Prognostics
Introduction
Irina M Shapiro is a notable inventor based in Chestnut Hill, MA (US). She has made significant contributions to the field of cancer research, particularly in the area of metastatic cancer. Her innovative work has the potential to change how tumors are assessed for their likelihood of metastasizing.
Latest Patents
Irina holds a patent for her invention titled "Alternatively spliced mRNA isoforms as prognostic indicators for metastatic cancer." This invention provides a method for identifying a tumor as likely to metastasize by quantitating alternatively spliced mRNA isoforms of specific genes in a tumor sample. The method compares the levels of these isoforms or RNA binding proteins to a predetermined non-metastasizing control, offering a promising approach to cancer prognosis.
Career Highlights
Throughout her career, Irina has worked with prestigious institutions, including the Massachusetts Institute of Technology and Montefiore Medical Center. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Irina has collaborated with notable colleagues such as Frank B Gertler and Christopher Boyce Burge. These partnerships have further enhanced her research and innovation in cancer prognostics.
Conclusion
Irina M Shapiro's work exemplifies the intersection of innovation and medical research. Her contributions to cancer prognosis through her patented methods highlight the importance of scientific advancements in improving patient outcomes.